Neuromuscular disease caused by qualitative or quantitative defects of dysferlin

MONDO:0016145

Also known as: dysferlinopathy, qualitative or quantitative defects of dysferlin

3 clinical trials for this condition and its sub-types, 0 tagged with Neuromuscular disease caused by qualitative or quantitative defects of dysferlin itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hereditary neurological disease (5772) ↑ Qualitative or quantitative protein defects in neuromuscular diseases (30)

Sub-types of Neuromuscular disease caused by qualitative or quantitative defects of dysferlin

Autosomal recessive limb-girdle muscular dystrophy type 2B 3 trials
Miyoshi muscular dystrophy 1 0 trials
Congenital myopathy, Paradas type 0 trials
Distal myopathy with anterior tibial onset 0 trials

Including sub-types (3) Tagged with Neuromuscular disease caused by qualitative or quantitative defects of dysferlin (0)

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

Major study aims to better measure muscular dystrophy progression

Knowledge-focused Recruiting now

This 24-month observational study will follow up to 1000 people with certain types of muscular dystrophy (LGMD, DM2, and late-onset Pompe disease) aged 6-50. Researchers want to see if specific physical tests, like the North Star Assessment and a 100-meter walk, are good ways to …

Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:57 UTC

Neuromuscular disease caused by qualitative or quantitative defects of dysferlin

Where it sits in the disease tree

Major study aims to better measure muscular dystrophy progression